Disproportional signal of pericarditis with biological diseasemodifying antirheumatic drugs (bDMARDs) in patients with ankylosing spondylitis: a disproportionality analysis in the FAERS database. [PDF]
Front PharmacolXia S +7 more
europepmc +1 more source
Predictors of functional improvement and pain reduction in rheumatoid arthritis patients who achieved low disease activity with disease-modifying antirheumatic drugs: a retrospective study of the FIRST Registry. [PDF]
Arthritis Res TherOchi S +3 more
europepmc +1 more source
Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs. [PDF]
RMD OpenAl Mohamad F +9 more
europepmc +1 more source
Latent and active tuberculosis development in patients with rheumatoid arthritis receiving biologic disease-modifying antirheumatic drugs: A single-center prospective study. [PDF]
PLoS OneHai BB +5 more
europepmc +1 more source
Managing Disease-Modifying Antirheumatic Drugs (DMARDs) for Patients Undergoing Elective Spine Surgery: A Pilot Survey. [PDF]
Spine Surg Relat ResMamaril-Davis JC +6 more
europepmc +1 more source
Clinical and immunological responses to COVID-19 vaccination in rheumatoid arthritis patients on disease modifying antirheumatic drugs: a cross-sectional study. [PDF]
J Rheum DisEerike M +11 more
europepmc +1 more source
Correction: Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs. [PDF]
RMD Openeuropepmc +1 more source